Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 17
1979 39
1980 47
1981 72
1982 81
1983 81
1984 112
1985 131
1986 115
1987 117
1988 96
1989 98
1990 83
1991 90
1992 77
1993 63
1994 61
1995 56
1996 45
1997 34
1998 51
1999 45
2000 37
2001 41
2002 35
2003 49
2004 44
2005 43
2006 51
2007 61
2008 64
2009 59
2010 50
2011 53
2012 73
2013 97
2014 80
2015 74
2016 75
2017 66
2018 72
2019 69
2020 74
2021 76
2022 65
2023 67
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

2,936 results

Results by year

Filters applied: . Clear all
Page 1
Domperidone: review of pharmacology and clinical applications in gastroenterology.
Reddymasu SC, Soykan I, McCallum RW. Reddymasu SC, et al. Am J Gastroenterol. 2007 Sep;102(9):2036-45. doi: 10.1111/j.1572-0241.2007.01255.x. Epub 2007 May 3. Am J Gastroenterol. 2007. PMID: 17488253 Review.
Domperidone is a dopamine-2 receptor antagonist. It acts as an antiemetic and a prokinetic agent through its effects on the chemoreceptor trigger zone and motor function of the stomach and small intestine. ...In view of this additional clinical exposure of domperidone …
Domperidone is a dopamine-2 receptor antagonist. It acts as an antiemetic and a prokinetic agent through its effects on the chemorece …
[Domperidone (Motilium)].
Tauber A, Eschar J. Tauber A, et al. Harefuah. 1982 Apr 15;102(8):356-7. Harefuah. 1982. PMID: 7117983 Hebrew. No abstract available.
Drugs in Focus: Domperidone.
Puoti MG, Assa A, Benninga M, Broekaert IJ, Carpi FJM, Deganello Saccomani M, Dolinsek J, Homan M, Mas E, Miele E, Tzivinikos C, Thomson M, Borrelli O. Puoti MG, et al. J Pediatr Gastroenterol Nutr. 2023 Aug 1;77(2):e13-e22. doi: 10.1097/MPG.0000000000003822. Epub 2023 May 9. J Pediatr Gastroenterol Nutr. 2023. PMID: 37159421 Review.
Domperidone is a peripheral dopamine-2 receptor antagonist with prokinetic and antiemetic properties. ...Based on this, the purpose of this review is to summarize all evidence on the efficacy of domperidone for the treatment of GI disorders in infants and children a …
Domperidone is a peripheral dopamine-2 receptor antagonist with prokinetic and antiemetic properties. ...Based on this, the purpose o …
Domperidone: The Forbidden Fruit.
Anderson PO. Anderson PO. Breastfeed Med. 2017 Jun;12:258-260. doi: 10.1089/bfm.2017.0043. Epub 2017 Apr 25. Breastfeed Med. 2017. PMID: 28440671 Review. No abstract available.
Domperidone.
Cherian S, Sachdev HP, Puri RK. Cherian S, et al. Indian Pediatr. 1989 Sep;26(9):932-5. Indian Pediatr. 1989. PMID: 2699318 Review. No abstract available.
Domperidone.
Champion MC. Champion MC. Gen Pharmacol. 1988;19(4):499-505. doi: 10.1016/0306-3623(88)90153-x. Gen Pharmacol. 1988. PMID: 3044918 Review. No abstract available.
Use of peripheral dopamine antagonist (Motilium) in the treatment of dyspeptic complaints of different origin and in nausea, vomiting.
Sásdi A. Sásdi A. Ther Hung. 1989;37(3):172-5. Ther Hung. 1989. PMID: 2588201
The incidence of dyspepsias and emesis occurring either as accompanying symptoms of gynaecological operations or as independent clinical conditions, therapeutic means for controlling these conditions and the mechanism of action and clinical usefulness of the dopamine antagonist …
The incidence of dyspepsias and emesis occurring either as accompanying symptoms of gynaecological operations or as independent clinical con …
Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis.
Qi Q, Wang N, Liu H, Li Y. Qi Q, et al. BMC Gastroenterol. 2023 Oct 31;23(1):370. doi: 10.1186/s12876-023-03014-9. BMC Gastroenterol. 2023. PMID: 37907846 Free PMC article.
Network meta-analysis showed that metoclopramide had a higher total efficacy rate than mosapride (OR: 3.53, 95%CI: 1.70-7.47), domperidone (OR: 2.29, 95%CI: 1.16-4.63), itopride(OR: 2.77, 95%CI: 1.41-5.59), acotiamide(OR: 2.63, OR: 1.33-5.36), and placebo(OR: 5.68, 95%CI: …
Network meta-analysis showed that metoclopramide had a higher total efficacy rate than mosapride (OR: 3.53, 95%CI: 1.70-7.47), domperidon …
Domperidone.
Bateman DN. Bateman DN. Br Med J (Clin Res Ed). 1985 Apr 6;290(6474):1079. doi: 10.1136/bmj.290.6474.1079-a. Br Med J (Clin Res Ed). 1985. PMID: 3921116 Free PMC article. No abstract available.
2,936 results